| Lauren H Rucker, PA-C | |
|
2900 12th Ave N Ste 140w, Billings, MT 59101-7507 | |
| (406) 237-5050 | |
| (406) 238-6599 |
| Full Name | Lauren H Rucker |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 12 Years |
| Location | 2900 12th Ave N Ste 140w, Billings, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750625687 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 20576 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ortho Montana, Psc | 5193627404 | 33 |
News Archive
Celgene International Sàrl announced that clinical data from two investigational studies evaluating the use of REVLIMID (lenalidomide) either with rituximab or following a rituximab-containing regimen in patients with chronic lymphocytic leukaemia were presented at the 52nd American Society of Hematology annual meeting.
The University of Michigan, University of California Los Angeles, University of Pennsylvania and Yale University have teamed up to launch a new initiative to educate nurses and physicians together to serve as leaders, researchers and change agents in health care, community health and public policy.
Anti-NMDAR encephalitis is an autoimmune brain illness that is often mistaken by a psychiatric disorder since it causes psychoses and other behaviour alterations. Despite having these similarities, the illness does not respond to common antipsychotic treatments.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced positive top-line results from a pivotal, non-human primate study of its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin) against an inhaled lethal dose of tularemia. A 14-day course of Restanza achieved a 100% survival rate at the doses tested. All of the ten animals in the study that received 16 mg/kg once-a-day of Restanza (approximate to a human dose of 300 mg) within 24 hours after exposure to a lethal dose of inhaled tularemia survived while only one of the ten animals that received placebo survived.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren H Rucker, PA-C 2900 12th Ave N Ste 140w, Billings, MT 59101-7507 Ph: (406) 237-5050 | Lauren H Rucker, PA-C 2900 12th Ave N Ste 140w, Billings, MT 59101-7507 Ph: (406) 237-5050 |
News Archive
Celgene International Sàrl announced that clinical data from two investigational studies evaluating the use of REVLIMID (lenalidomide) either with rituximab or following a rituximab-containing regimen in patients with chronic lymphocytic leukaemia were presented at the 52nd American Society of Hematology annual meeting.
The University of Michigan, University of California Los Angeles, University of Pennsylvania and Yale University have teamed up to launch a new initiative to educate nurses and physicians together to serve as leaders, researchers and change agents in health care, community health and public policy.
Anti-NMDAR encephalitis is an autoimmune brain illness that is often mistaken by a psychiatric disorder since it causes psychoses and other behaviour alterations. Despite having these similarities, the illness does not respond to common antipsychotic treatments.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced positive top-line results from a pivotal, non-human primate study of its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin) against an inhaled lethal dose of tularemia. A 14-day course of Restanza achieved a 100% survival rate at the doses tested. All of the ten animals in the study that received 16 mg/kg once-a-day of Restanza (approximate to a human dose of 300 mg) within 24 hours after exposure to a lethal dose of inhaled tularemia survived while only one of the ten animals that received placebo survived.
› Verified 4 days ago
Kirk Kenfield, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Alexander Ramsey, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Kaitlyn Steele, PA-C Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: 1611 Zimmerman Trl, Billings, MT 59102 Phone: 406-248-3607 | |
Trenay Hart, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4141 Fax: 406-237-4126 | |
Melanie Schmitz, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Jamaica Rachel Moore, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 North 29th Street, Billings Clinic, Billings, MT 59101 Phone: 406-238-2410 | |
Kortney Ann Gaughan, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2900 12th Ave N Ste 160w, Billings, MT 59101 Phone: 406-237-4580 |